Sabra Healthcare REIT (SBRA) Stock: Buy, Sell, or Hold?
$21.32
-0.15 (-0.70%)
▼
5d:
+4.77%
30d:
+11.04%
90d:
+5.6%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (25%)
Quality Score
52/100
Position
EXTENDED
30-Day Fair Range
$18.87 – $20.43
Position: EXTENDED
Forward P/E & Valuation
29.4x
FAIR
vs 25.7x historical avg
Wall Street Target
$22.50
+5.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$18.89 / $21.56
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SBRA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.30
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.92
2.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $21.32, which is considered extended relative to its 30-day fair value range of $18.87 to $20.43. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.4) compared to its historical average (25.7). At these levels, the market is pricing in 4.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is approaching resistance at $21.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBRA scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is approaching resistance at $21.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBRA scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.87 -
$20.43
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
24.8%
Trading Range & Key Levels
30-Day Trading Range
$18.87 -
$20.43
Current vs Trading Range
EXTENDED
Support Level
$18.89
Resistance Level
$21.56
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (10/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($22.50)
- NEUTRAL: Market pricing in 4.6% annual earnings growth - fairly valued
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
29.41
Wall Street Target
$22.50
(+5.5%)
Revenue Growth (YoY)
31.6%
Earnings Growth (YoY)
22.2%
Profit Margin
7.7%
Valuation Premium vs History
+4.6% premium
PE vs Historical
29.4 vs 25.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.6%
(market-implied from PE analysis)
1-Year Target
$22.30
(+5%)
2-Year Target
$23.33
(+9%)
3-Year Target
$24.40
(+14%)
3-Yr Target (if PE normalizes)
(PE: 29→26)
PE COMPRESSION
$21.32
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.4, Growth: 121.9%)
$71.95
(+238%)
Base:
(SPY PE: 19.9, Growth: 121.9%)
$48.59
(+128%)
Bear:
(PE: 16.9, Growth: 121.9%)
$41.31
(+94%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (29x PE) as earnings recover.
Forward PE: 32.15 | Forward EPS (Implied): $0.66
Bull Case
$25.74
(+21%)
Analyst growth 15.0%, PE expands to 33.8
Base Case
$21.32
(0%)
Market implied 0.0%, PE stable at 32.2
Bear Case
$16.31
(-24%)
Severe decline -15.0%, PE contracts to 28.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share SBRA Analysis
Share this live SBRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SBRA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Feb 4, 2026
Daily AI digest
AI Retail Discussion Summary:
Sabra Health Care REIT, Inc. ($SBRA) announced the release date for its Q4 2025 earnings and declared a dividend of $.30 per share.
Key Retail Themes:
earnings announcement
dividend declaration
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 12:52 AM ET
Data refreshes hourly during market hours. Next update: 1:52 AM
Data refreshes hourly during market hours. Next update: 1:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
23 analysts |
$99 | 43 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
22 analysts |
$262 | 44 HOLD |
|
AHR
American Healthcare REIT… |
STRONG BUY
16 analysts |
$64 | 41 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
14 analysts |
$44 | 56 HOLD |
|
DOC
Healthpeak Properties Inc |
HOLD
22 analysts |
$22 | 52 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SBRA Research Pages
